Abstract

The use of bioactive glasses in dentistry, reconstructive surgery, and in the treatment of infections can be considered broadly beneficial based on the emerging literature about the potential bioactivity and biocompatibility of these materials, particularly with reference to Bioglass® 45S5, BonAlive® and 19-93B3 bioactive glasses. Several investigations have been performed (i) to obtain bioactive glasses in different forms, such as bulk materials, powders, composites, and porous scaffolds and (ii) to investigate their possible applications in the biomedical field. Although in vivo studies in animals provide us with an initial insight into the biological performance of these systems and represent an unavoidable phase to be performed before clinical trials, only clinical studies can demonstrate the behavior of these materials in the complex physiological human environment. This paper aims to carefully review the main published investigations dealing with clinical trials in order to better understand the performance of bioactive glasses, evaluate challenges, and provide an essential source of information for the tailoring of their design in future applications. Finally, the paper highlights the need for further research and for specific studies intended to assess the effect of some specific dissolution products from bioactive glasses, focusing on their osteogenic and angiogenic potential.

Highlights

  • Biomaterials, natural or synthetic, are used in regenerative medicine, dentistry, and in the treatment of infections in a broad range of applications to replace damaged tissues or to restore biological functions [1,2,3,4,5,6,7]

  • The purpose of this review is to deliver a literature overview of the clinical results and conclusions about different applications of bioactive glasses, with a special emphasis on three main compositions developed in the last few decades: the standard silicate glass (45S5 or Bioglass®), a glass–ceramic (S53P4 bioactive glass or BonAlive®), and a borate-based glass (13-93B3 bioactive glass) [9,10,13,17,19,28,29,30], which appears promising in wound healing

  • The results showed the successful biodegradation of the glass, leading to well-loaded and stable implants

Read more

Summary

Introduction

Biomaterials, natural or synthetic, are used in regenerative medicine, dentistry, and in the treatment of infections in a broad range of applications to replace damaged tissues or to restore biological functions [1,2,3,4,5,6,7]. A material could be an optimal biomaterial usable for clinical applications if it has the following properties: (1) it is available at any time and in any amount; (2) it is non-expensive; (3) it is inert so that it prevents body reactions or infections when implanted; (4) it is not toxic; (5) it could be shaped or molded during the operation; (6) it does not require any additional surgery time; (7) it does not disturb medical follow-up procedures during tests (e.g., computed tomography, magnetic resonance imaging, etc.) In this context, bioactive glasses (BG), originally developed by Hench starting in 1969, are considered a group of reactive materials with attractive properties, in terms of biocompatibility and of bioactivity; this means that they show the ability to form bonds with mineralized bone tissue in the physiological body environment [8,9,10,11,12]. Applications and clinical trials involving the three considered main compositions are reported and discussed in detail

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call